Biomarker correlates of clinical response with FLT3L/nivo backbone treatment in the multi-cohort phase 1 porter platform trial in metastatic castration-resistant prostate cancer patients Meeting Abstract


Authors: Shotts, K.; Howes, T.; Yu, J.; Densmore, J.; Da Silva, D.; Kumar, D.; Santulli-Marotto, S.; Cabanski, C.; Eisenbeisz, E.; Ivison, G.; Mayer, A.; Moore, J.; Jones, D.; Kraynyak, K.; Dolgoter, A.; Chen, R.; Butterfield, L.; LaVallee, T.; Bucktrout, S.; Padron, L.; Dugan, U.; Yellin, M.; Keler, T.; O'Donnell-Tormey, J.; Fairchild, J.; Salvador, L.; Wentzel, K.; Fong, L.; Subudhi, S.; Bhardwaj, N.; Autio, K.; Galsky, M.
Abstract Title: Biomarker correlates of clinical response with FLT3L/nivo backbone treatment in the multi-cohort phase 1 porter platform trial in metastatic castration-resistant prostate cancer patients
Meeting Title: 37th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2022)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 10
Issue: Suppl. 2
Meeting Dates: 2022 Nov 8-12
Meeting Location: Boston, MA
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2022-11-01
Start Page: A585
Language: English
ACCESSION: WOS:000919423400526
DOI: 10.1136/jitc-2022-SITC2022.0559
PROVIDER: wos
Notes: Meeting Abstract: 559 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karen Anne Autio
    120 Autio